Finance

Lists
Why is VENUSREM down 2,43%?
Dive Deeper
VENUSREM:NSE
Venus Remedies Ltd
₹1 581,00
-2,43%
(-39,40) 1D
13 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VENUSREM...
Open
₹1 605,00
High
₹1 627,30
Low
₹1 561,10
Mkt. cap
20,90 mjd
Avg. vol.
29,62 k
Volume
18,76 k
Dividend
0,63%
Quarterly dividend
₹2,50
Ex-dividend date
07 Aug. 2026
P/E ratio
18,19
52-wk high
₹2 044,30
52-wk low
₹432,10
EPS
₹86,92
Shares outstanding
12,34 m
No. of employees
1 k
Open
₹1 605,00
High
₹1 627,30
Low
₹1 561,10
Mkt. cap
20,90 mjd
Avg. vol.
29,62 k
Volume
18,76 k
Dividend
0,63%
Quarterly dividend
₹2,50
Ex-dividend date
07 Aug. 2026
P/E ratio
18,19
52-wk high
₹2 044,30
52-wk low
₹432,10
EPS
₹86,92
Shares outstanding
12,34 m
No. of employees
1 k
News stories
From web sources and news partners
About Venus Remedies Ltd
CEOSaransh Chaudhary
Employees1,47 k
Founded1989
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,93 mjd
1,80 mjd
2,59 mjd
1,79 mjd
Cost of goods sold
1,07 mjd
862,50 m
1,22 mjd
842,80 m
Cost of revenue
1,07 mjd
862,50 m
1,22 mjd
842,80 m
Research and development expenses
43,50 m
47,30 m
51,03 m
46,70 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
501,30 m
517,60 m
693,21 m
557,20 m
Operating expense
606,50 m
630,50 m
788,52 m
671,60 m
Total operating expenses
1,68 mjd
1,49 mjd
2,00 mjd
1,51 mjd
Operating income
247,90 m
309,60 m
589,89 m
274,20 m
Other non operating income
17,10 m
25,20 m
-54,65 m
26,20 m
EBT including unusual items
264,90 m
334,70 m
615,93 m
300,40 m
EBT excluding unusual items
264,90 m
334,70 m
556,56 m
300,40 m
Income tax expense
63,60 m
78,90 m
141,14 m
70,70 m
Effective tax rate
24,01%
23,57%
22,92%
23,54%
Other operating expenses
-
-
-23,33 m
-
Net income
201,30 m
255,80 m
474,79 m
229,70 m
Net profit margin
10,44%
14,19%
18,30%
12,84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
21,39 m
-
Interest expense
-100,00 k
-100,00 k
-67,00 k
-
Net interest expenses
-100,00 k
-100,00 k
21,32 m
-
Depreciation and amortization charges
61,70 m
65,60 m
67,61 m
67,70 m
EBITDA
309,65 m
358,59 m
631,04 m
338,38 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme